These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8436117)

  • 1. Interleukin-1 beta-specific partial agonists defined by site-directed mutagenesis studies.
    Guinet F; Guitton JD; Gault N; Folliard F; Touchet N; Cherel JM; Crespo A; Destourbe A; Bertrand P; Denefle P
    Eur J Biochem; 1993 Feb; 211(3):583-90. PubMed ID: 8436117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutational analysis of receptor binding sites of interleukin-1 beta: differences in binding of human interleukin-1 beta muteins to human and mouse receptors.
    Grütter MG; van Oostrum J; Priestle JP; Edelmann E; Joss U; Feige U; Vosbeck K; Schmitz A
    Protein Eng; 1994 May; 7(5):663-71. PubMed ID: 8073036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion mutants of human interleukin 1 beta with significantly reduced agonist properties: search for the agonist/antagonist switch in ligands to the interleukin 1 receptors.
    Simoncsits A; Bristulf J; Tjörnhammar ML; Cserzö M; Pongor S; Rybakina E; Gatti S; Bartfai T
    Cytokine; 1994 Mar; 6(2):206-14. PubMed ID: 8032002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.
    Labriola-Tompkins E; Chandran C; Kaffka KL; Biondi D; Graves BJ; Hatada M; Madison VS; Karas J; Kilian PL; Ju G
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11182-6. PubMed ID: 1837145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed mutagenesis--molecular biology and rational drug design.
    Ju G; Labriola-Tompkins E; Varnell T; Madison V; Graves B
    Agents Actions Suppl; 1995; 47():155-9. PubMed ID: 7785490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of type-II interleukin-1 receptors. Heterogeneity of B-cell interleukin-1 binding created by dimerization of type-II interleukin-1 receptors.
    Cronkhite RI; Lobick JJ; Plate JM
    Hum Immunol; 1993 Feb; 36(2):128-36. PubMed ID: 8463123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.
    Boraschi D; Bossù P; Ruggiero P; Tagliabue A; Bertini R; Macchia G; Gasbarro C; Pellegrini L; Melillo G; Ulisse E; Visconti U; Bizzarri C; Del Grosso E; Mackay AR; Frascotti G; Frigerio F; Grifantini R; Grandi G
    J Immunol; 1995 Nov; 155(10):4719-25. PubMed ID: 7594472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple amino acid substitutions suggest a structural basis for the separation of biological activity and receptor binding in a mutant interleukin-1 beta protein.
    Auron PE; Quigley GJ; Rosenwasser LJ; Gehrke L
    Biochemistry; 1992 Jul; 31(29):6632-8. PubMed ID: 1386253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic alleles at position 121 define a functional domain of human interleukin-1 beta.
    Ambrosetti DC; Palla E; Mirtella A; Galeotti C; Solito E; Navarra P; Parente L; Melli M
    Eur J Biochem; 1996 Jun; 238(2):308-16. PubMed ID: 8681939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification to homogeneity and NH2-terminal amino acid sequence of a novel interleukin 1 species derived from a human B cell line.
    Rimsky L; Wakasugi H; Ferrara P; Robin P; Capdevielle J; Tursz T; Fradelizi D; Bertoglio J
    J Immunol; 1986 May; 136(9):3304-10. PubMed ID: 3485686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function analysis of murine interleukin 1: biologically active polypeptides are at least 127 amino acids long and are derived from the carboxyl terminus of a 270-amino acid precursor.
    DeChiara TM; Young D; Semionow R; Stern AS; Batula-Bernardo C; Fiedler-Nagy C; Kaffka KL; Kilian PL; Yamazaki S; Mizel SB
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8303-7. PubMed ID: 3022289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression in Escherichia coli of fully active recombinant human IL 1 beta: comparison with native human IL 1 beta.
    Tocci MJ; Hutchinson NI; Cameron PM; Kirk KE; Norman DJ; Chin J; Rupp EA; Limjuco GA; Bonilla-Argudo VM; Schmidt JA
    J Immunol; 1987 Feb; 138(4):1109-14. PubMed ID: 2949012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loop substitution as a tool to identify active sites of interleukin-1 beta.
    Palla E; Bensi G; Solito E; Buonamassa DT; Fassina G; Raugei G; Spano F; Galeotti C; Mora M; Domenighini M
    J Biol Chem; 1993 Jun; 268(18):13486-92. PubMed ID: 7685764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of strain and interleukin-1 in articular cartilage: effects on proteoglycan synthesis in chondrocytes.
    Gassner RJ; Buckley MJ; Studer RK; Evans CH; Agarwal S
    Int J Oral Maxillofac Surg; 2000 Oct; 29(5):389-94. PubMed ID: 11071247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of an interleukin-1 beta mutant with reduced bioactivity shows multiple subtle changes in conformation that affect protein-protein recognition.
    Camacho NP; Smith DR; Goldman A; Schneider B; Green D; Young PR; Berman HM
    Biochemistry; 1993 Aug; 32(34):8749-57. PubMed ID: 8364024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of regions in interleukin-1 alpha important for activity.
    Gayle RB; Poindexter K; Cosman D; Dower SK; Gillis S; Hopp T; Jerzy R; Kronheim S; Lum V; Lewis A
    J Biol Chem; 1993 Oct; 268(29):22105-11. PubMed ID: 8408069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.
    Arend WP; Welgus HG; Thompson RC; Eisenberg SP
    J Clin Invest; 1990 May; 85(5):1694-7. PubMed ID: 2139669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 beta secretion. A possible multistep process that is regulated in a cell type-specific manner.
    Siders WM; Mizel SB
    J Biol Chem; 1995 Jul; 270(27):16258-64. PubMed ID: 7608192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human interleukin 1 mediates cartilage matrix degradation.
    Krakauer T; Oppenheim JJ; Jasin HE
    Cell Immunol; 1985 Mar; 91(1):92-9. PubMed ID: 3871667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction and site-specific mutagenesis of residues in transmembrane alpha-helices of proton-pumping nicotinamide nucleotide transhydrogenases from Escherichia coli and bovine heart mitochondria.
    Holmberg E; Olausson T; Hultman T; Rydström J; Ahmad S; Glavas NA; Bragg PD
    Biochemistry; 1994 Jun; 33(24):7691-700. PubMed ID: 8011636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.